BryoSphere Biotechnologies

Sustainable specialty chemical manufacturing using engineered moss

BryoSphere Biotechnologies operates in sustainable manufacturing based in Canada, founded in 2022.

Profile

BryoSphere Biotechnologies uses moss plants and biotechnology techniques to synthesize rare, plant-derived specialty compounds. By harnessing the genetic information of a variety of plants, BryoSphere achieves the production of rare compounds with significantly higher yields compared to those found in their natural counterparts, thereby enhancing accessibility. Currently, BryoSphere is dedicated to the development of two key products: one for addressing skin hyperpigmentation in topical treatments, and another as an anti-cancer drug.

Within the sustainable manufacturing space, the company focuses on its core offering rather than a broad product line.

Its base of operations is Canada.

The company is listed at the SOSV portfolio company stage of development.

Its team size is recorded as 2-10 employees.

Website: bryosphere.ca